Cargando…
Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19
OBJECTIVE: To determine the nationwide prevalence of hyperuricemia in China and evaluate its trends and associated risk factors. METHODS: Using a multi-stage, stratified, cluster-randomized sampling design, two cross-sectional surveys (representative of national and provincial information) were cond...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858821/ https://www.ncbi.nlm.nih.gov/pubmed/35197964 http://dx.doi.org/10.3389/fimmu.2021.791983 |
_version_ | 1784654319730032640 |
---|---|
author | Zhang, Mei Zhu, Xiaoxia Wu, Jing Huang, Zhengjing Zhao, Zhenping Zhang, Xiao Xue, Yu Wan, Weiguo Li, Chun Zhang, Wenrong Wang, Linhong Zhou, Maigeng Zou, Hejian Wang, Limin |
author_facet | Zhang, Mei Zhu, Xiaoxia Wu, Jing Huang, Zhengjing Zhao, Zhenping Zhang, Xiao Xue, Yu Wan, Weiguo Li, Chun Zhang, Wenrong Wang, Linhong Zhou, Maigeng Zou, Hejian Wang, Limin |
author_sort | Zhang, Mei |
collection | PubMed |
description | OBJECTIVE: To determine the nationwide prevalence of hyperuricemia in China and evaluate its trends and associated risk factors. METHODS: Using a multi-stage, stratified, cluster-randomized sampling design, two cross-sectional surveys (representative of national and provincial information) were conducted in 31 provinces (autonomous regions and municipalities) in mainland China, with 166, 861 Chinese adults in 2015–16 and 168, 351 in 2018–19. Serum uric acid (SUA) levels of all participants were measured after a >10-hour overnight fast. Hyperuricemia (HUA) was defined when SUA was >420 μmol/L. Prevalence estimates were weighted to represent the total population considering the complex sampling design. Multivariable logistic regression models was used to estimate factors associated with HUA. RESULTS: The overall hyperuricemia prevalence in the Chinese adult population was 11.1% (95% confidence interval 10.3% to 11.8%) in 2015–16 and 14.0% (13.1% to 14.8%) in 2018–19; an alarming rise was observed in the three years. Hyperuricemia was more common in men with 19.3% (17.9% to 20.7%) in 2015–16 and 24.4% (23.0% to 25.8%) in 2018–19, although the prevalence also escalated from 2.8% (2.5% to 3.0%) in 2015–16 to 3.6% (3.2% to 4.0%) in 2018–19 in women. The hyperuricemia risk factors include the urban culture, settlement in the East, Zhuang descent, high education, heavy or frequent beer drinking, high red meat intake, physical inactivity, high body mass index, central obesity, hypertension, hyperlipidemia, and low glomerular filtration rate. CONCLUSION: The estimated hyperuricemia prevalence among Chinese adults was 14.0% in 2018-19; significant escalating trends were observed between 2015-16 and 2018-19. |
format | Online Article Text |
id | pubmed-8858821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88588212022-02-22 Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 Zhang, Mei Zhu, Xiaoxia Wu, Jing Huang, Zhengjing Zhao, Zhenping Zhang, Xiao Xue, Yu Wan, Weiguo Li, Chun Zhang, Wenrong Wang, Linhong Zhou, Maigeng Zou, Hejian Wang, Limin Front Immunol Immunology OBJECTIVE: To determine the nationwide prevalence of hyperuricemia in China and evaluate its trends and associated risk factors. METHODS: Using a multi-stage, stratified, cluster-randomized sampling design, two cross-sectional surveys (representative of national and provincial information) were conducted in 31 provinces (autonomous regions and municipalities) in mainland China, with 166, 861 Chinese adults in 2015–16 and 168, 351 in 2018–19. Serum uric acid (SUA) levels of all participants were measured after a >10-hour overnight fast. Hyperuricemia (HUA) was defined when SUA was >420 μmol/L. Prevalence estimates were weighted to represent the total population considering the complex sampling design. Multivariable logistic regression models was used to estimate factors associated with HUA. RESULTS: The overall hyperuricemia prevalence in the Chinese adult population was 11.1% (95% confidence interval 10.3% to 11.8%) in 2015–16 and 14.0% (13.1% to 14.8%) in 2018–19; an alarming rise was observed in the three years. Hyperuricemia was more common in men with 19.3% (17.9% to 20.7%) in 2015–16 and 24.4% (23.0% to 25.8%) in 2018–19, although the prevalence also escalated from 2.8% (2.5% to 3.0%) in 2015–16 to 3.6% (3.2% to 4.0%) in 2018–19 in women. The hyperuricemia risk factors include the urban culture, settlement in the East, Zhuang descent, high education, heavy or frequent beer drinking, high red meat intake, physical inactivity, high body mass index, central obesity, hypertension, hyperlipidemia, and low glomerular filtration rate. CONCLUSION: The estimated hyperuricemia prevalence among Chinese adults was 14.0% in 2018-19; significant escalating trends were observed between 2015-16 and 2018-19. Frontiers Media S.A. 2022-02-07 /pmc/articles/PMC8858821/ /pubmed/35197964 http://dx.doi.org/10.3389/fimmu.2021.791983 Text en Copyright © 2022 Zhang, Zhu, Wu, Huang, Zhao, Zhang, Xue, Wan, Li, Zhang, Wang, Zhou, Zou and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhang, Mei Zhu, Xiaoxia Wu, Jing Huang, Zhengjing Zhao, Zhenping Zhang, Xiao Xue, Yu Wan, Weiguo Li, Chun Zhang, Wenrong Wang, Linhong Zhou, Maigeng Zou, Hejian Wang, Limin Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 |
title | Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 |
title_full | Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 |
title_fullStr | Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 |
title_full_unstemmed | Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 |
title_short | Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19 |
title_sort | prevalence of hyperuricemia among chinese adults: findings from two nationally representative cross-sectional surveys in 2015–16 and 2018–19 |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858821/ https://www.ncbi.nlm.nih.gov/pubmed/35197964 http://dx.doi.org/10.3389/fimmu.2021.791983 |
work_keys_str_mv | AT zhangmei prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT zhuxiaoxia prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT wujing prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT huangzhengjing prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT zhaozhenping prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT zhangxiao prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT xueyu prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT wanweiguo prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT lichun prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT zhangwenrong prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT wanglinhong prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT zhoumaigeng prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT zouhejian prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 AT wanglimin prevalenceofhyperuricemiaamongchineseadultsfindingsfromtwonationallyrepresentativecrosssectionalsurveysin201516and201819 |